Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss

Wegovy (semaglutide 2.4 mg) is available through Asda's Online Doctor service for weight management, with monthly costs typically ranging from £169 to £229 depending on dosage strength. This prescription-only medicine requires clinical assessment and ongoing monitoring through Asda's digital pharmacy platform. Whilst significantly more expensive than NHS provision (£9.90 per prescription in England), private access through Asda offers more immediate availability compared to NHS specialist weight management services, where waiting times can be lengthy. Understanding the full cost implications and treatment requirements is essential before commencing this long-term therapy.
Summary: Wegovy costs £169–£229 per month at Asda Pharmacy, including medication and clinical consultation through their Online Doctor service.
Wegovy (semaglutide 2.4 mg) is available through Asda's Online Doctor service as part of their weight management programme. As of 2024, the monthly cost for Wegovy at Asda typically ranges from £169 to £229 per month, depending on the dosage strength required during your treatment journey. This pricing structure reflects the tiered dosing schedule that Wegovy follows, starting at lower doses and gradually increasing to the maintenance dose of 2.4 mg weekly. These prices are subject to change, so it's advisable to check Asda's current pricing.
The cost includes both the medication and the clinical consultation required for prescription. Wegovy is administered via pre-filled, single-use injection pens, with a monthly supply typically containing 4 pens (one for each weekly dose).
Patients should budget for a minimum treatment duration of several months, as clinical trials demonstrate that semaglutide's weight loss effects are most pronounced with sustained use over 12–16 months. Research shows that discontinuing treatment often results in weight regain. It's important to note that Wegovy is licensed specifically as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone treatment.
The long-term cost is an essential consideration when evaluating whether this treatment is suitable for your circumstances, alongside the lifestyle modifications necessary for successful weight management. Check with Asda regarding any available payment options, as these policies may vary.
Accessing Wegovy through Asda requires completing an online consultation process via their digital pharmacy platform. Patients cannot simply purchase Wegovy over the counter, as it is a prescription-only medicine (POM) that requires clinical assessment and ongoing monitoring. The process begins by visiting the Asda Online Doctor website and creating an account with your personal and medical details.
During the online consultation, you will complete a comprehensive medical questionnaire covering your weight history, BMI, previous weight loss attempts, current medications, and relevant medical conditions. This information is reviewed by a UK-registered clinician (either a GP or prescribing pharmacist) who will assess your suitability for Wegovy.
Wegovy is licensed for adults (aged 18 and over) with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. This differs from NHS funding criteria, which are more restrictive and require specialist weight management service involvement.
If approved, your prescription will be issued electronically and the medication typically dispatched directly to your home address via secure courier, usually arriving within 2–3 working days (though delivery times may vary). The service includes follow-up consultations at regular intervals to monitor your progress, assess tolerability, and adjust treatment as needed.
Wegovy is contraindicated in pregnancy. It should not be used during breast-feeding or by people with a personal history of severe hypersensitivity to semaglutide. You should use effective contraception during treatment and stop Wegovy at least 2 months before a planned pregnancy due to its long half-life.
It's important to be aware of serious side effect warning signs requiring urgent medical attention, including severe persistent abdominal pain (possible pancreatitis), gallbladder symptoms, dehydration from vomiting/diarrhoea, allergic reactions, and mood changes. If you miss a dose, take it within 5 days of the scheduled time; otherwise, skip that dose and resume your regular schedule with the next planned dose.

The cost difference between NHS and private Wegovy prescriptions is substantial, though NHS availability remains extremely limited. When available through the NHS, patients pay only the standard prescription charge of £9.90 per item in England (as of April 2024). Prescriptions are free in Scotland, Wales, and Northern Ireland. Patients with Prescription Prepayment Certificates (PPCs) pay a fixed upfront fee that covers all prescriptions during the certificate's validity period.
NICE guidance restricts NHS provision of Wegovy to specialist weight management services for patients meeting specific criteria. Importantly, NHS treatment with Wegovy is limited to a maximum of 2 years. The medication is prescribed for adults with either a BMI ≥35 kg/m² with at least one weight-related comorbidity, or a BMI ≥30 kg/m² with at least one weight-related comorbidity and a high risk of cardiovascular disease. These thresholds may be adjusted for certain ethnic groups.
In reality, availability varies significantly across different Integrated Care Boards (ICBs), with many areas still implementing services. Waiting times for NHS specialist weight management clinics can be lengthy and vary by location. This has created a situation where the medication is often more readily accessible through private healthcare.
Private provision through services like Asda (£169–£229 monthly) represents a significant financial burden compared to NHS prescription charges, but offers more immediate access. Over a 12-month treatment course, private patients might spend £2,000–£2,750, compared to approximately £119 for NHS patients in England paying prescription charges.
Some private health insurance policies may cover Wegovy, though this is uncommon and typically requires pre-authorisation with evidence of medical necessity. The substantial cost differential highlights the importance of exploring NHS options first, particularly for patients who would struggle to sustain long-term private costs.
Asda's Wegovy service provides a comprehensive package beyond simply dispensing medication. The service includes an initial clinical consultation, ongoing monitoring, prescription management, and medication delivery. When you enrol, the initial assessment evaluates your medical history, current health status, and suitability for semaglutide therapy. This consultation is conducted by UK-registered healthcare professionals with prescribing authority.
Once treatment commences, the service includes regular follow-up consultations scheduled at intervals aligned with your dose escalation schedule. These reviews typically occur every 4–8 weeks and involve assessing weight loss progress, monitoring for adverse effects, and providing guidance on managing common side effects such as nausea, constipation, or diarrhoea. The clinician will also reinforce the importance of dietary modifications and increased physical activity, as Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as monotherapy.
The medication itself is delivered in pre-filled, single-use injection pens with detailed instructions for subcutaneous self-administration. Each pen contains a single weekly dose, with a monthly supply typically containing 4 pens. The pens follow the standard titration schedule: 0.25 mg weekly for four weeks, then 0.5 mg, 1.0 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg weekly. Wegovy should be stored in a refrigerator before first use; after that, follow the storage instructions in the Patient Information Leaflet.
Sharps disposal guidance is provided, and patients should check with their local council or pharmacy about obtaining sharps bins and collection services, as arrangements vary by location. Patients should be vigilant for serious side effects requiring urgent medical attention, including severe persistent abdominal pain, gallbladder symptoms, dehydration, allergic reactions, or significant mood changes.
Asda's service also provides access to educational resources about weight management, healthy eating patterns, and physical activity recommendations. However, it does not include face-to-face consultations, dietitian support, or psychological counselling, which are often components of comprehensive NHS specialist weight management programmes. Patients requiring more intensive multidisciplinary support may need to seek additional services independently.
If you experience any suspected side effects, you can report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.
For patients who do not meet eligibility criteria for Wegovy or cannot afford the ongoing costs, Asda Pharmacy offers several alternative weight management options. Orlistat (Alli) is available without prescription for adults with BMI ≥28 kg/m² following a pharmacy consultation. Orlistat works by inhibiting pancreatic lipase, reducing dietary fat absorption by approximately 25% at the over-the-counter dose of 60 mg (the prescription-strength 120 mg version reduces absorption by about 30%). It costs significantly less than Wegovy (typically £20–£50 monthly) but requires strict adherence to a low-fat diet to minimise gastrointestinal side effects such as oily stools and faecal urgency.
Asda pharmacists can provide general weight management advice, including guidance on calorie reduction, portion control, and increasing physical activity in line with UK Chief Medical Officers' recommendations of 150 minutes of moderate-intensity activity weekly. The pharmacy stocks various over-the-counter supplements marketed for weight management, though patients should note that most dietary supplements lack robust clinical evidence for significant weight loss. Evidence-based approaches focus on sustained caloric deficit and behavioural change rather than supplementation.
Patients may also access NHS-funded programmes such as the NHS Digital Weight Management Programme, which provides 12 weeks of digital behavioural support at no cost for eligible individuals. This is typically accessed via GP referral, with availability varying by location. Commercial programmes like Slimming World or Weight Watchers offer structured group support, though these involve ongoing membership fees.
For individuals with severe obesity (typically BMI ≥40, or ≥35 with comorbidities, with lower thresholds for some ethnic groups), requesting GP referral to specialist NHS weight management services remains the most cost-effective route. These services provide multidisciplinary support including dietitians, psychologists, and exercise specialists, with potential access to medications or bariatric surgery for those meeting criteria. Patients should contact their GP to discuss which approach is most appropriate for their individual circumstances.
No, Wegovy is a prescription-only medicine requiring clinical assessment through Asda's Online Doctor service. You must complete a comprehensive medical questionnaire reviewed by a UK-registered clinician who will assess your suitability before issuing a prescription.
Yes, NHS Wegovy costs £9.90 per prescription in England (free in Scotland, Wales, and Northern Ireland) compared to £169–£229 monthly privately at Asda. However, NHS availability is restricted to specialist weight management services with specific eligibility criteria and often lengthy waiting times.
The monthly cost includes initial clinical consultation, ongoing monitoring reviews every 4–8 weeks, prescription management, medication delivery, and educational resources. It does not include face-to-face consultations, dietitian support, or psychological counselling available in comprehensive NHS programmes.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript